Why Is HELP Stock Rising Today?
The company announced positive topline results from its Phase 3 APPROACH study evaluating HLP003 as an adjunctive treatment for major depressive disorder.
The company announced positive topline results from its Phase 3 APPROACH study evaluating HLP003 as an adjunctive treatment for major depressive disorder.